223 related articles for article (PubMed ID: 15982324)
1. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Thasler WE; Schlott T; Thelen P; Hellerbrand C; Bataille F; Lichtenauer M; Schlitt HJ; Jauch KW; Weiss TS
Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324
[TBL] [Abstract][Full Text] [Related]
2. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Scholz A; Wiedenmann B; Miller LJ; Reubi JC
J Hepatol; 2006 Dec; 45(6):825-35. PubMed ID: 16935383
[TBL] [Abstract][Full Text] [Related]
3. Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma.
Dayoub R; Wagner H; Bataille F; Stöltzing O; Spruss T; Buechler C; Schlitt HJ; Weiss TS
Mol Med; 2011; 17(3-4):221-8. PubMed ID: 21152698
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
[TBL] [Abstract][Full Text] [Related]
5. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
6. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas.
Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF
Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275
[TBL] [Abstract][Full Text] [Related]
7. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
9. Tricellulin expression and its prognostic significance in primary liver carcinomas.
Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
11. Altered regulation of Prox1-gene-expression in liver tumors.
Dudas J; Mansuroglu T; Moriconi F; Haller F; Wilting J; Lorf T; Füzesi L; Ramadori G
BMC Cancer; 2008 Apr; 8():92. PubMed ID: 18400094
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma.
Sabit H; Tsuneyama K; Shimonishi T; Harada K; Cheng J; Ida H; Saku T; Saito K; Nakanuma Y
Pathol Int; 2001 Apr; 51(4):248-56. PubMed ID: 11350606
[TBL] [Abstract][Full Text] [Related]
16. MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an
Zailaie SA; Sergi CM
Ann Clin Lab Sci; 2022 Jan; 52(1):73-85. PubMed ID: 35181620
[TBL] [Abstract][Full Text] [Related]
17. Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma.
Yu HY; Xiang DR; Huang HJ; Li J; Sheng JF
Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):492-8. PubMed ID: 20943458
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
19. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
Gramantieri L; Giovannini C; Lanzi A; Chieco P; Ravaioli M; Venturi A; Grazi GL; Bolondi L
Liver Int; 2007 Sep; 27(7):997-1007. PubMed ID: 17696940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
